1-1 of 1
Hans-Peter Hartung, MD
Close
Sort by
Journal Articles

Treatment with Natalizumab in Patients with Multiple Sclerosis Is Associated with Increased Numbers of Circulating CD34+ Cells in the Peripheral Blood.

Fabian Zohren, MD, Akos Czibere, MD, Diamandis Toutzaris, MD, Hans-Peter Hartung, MD, Ingmar Bruns, MD, Rainer Haas, MD
Journal: Blood
Blood (2007) 110 (11): 4916.
https://doi.org/10.1182/blood.V110.11.4916.4916
Published: 2007